Stay updated on Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial
Sign up to get notified when there's something new on the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page.

Latest updates to the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now loads a 403 Forbidden screen, replacing the study details with a standard error page. This indicates restricted access to the study record rather than showing its content.SummaryDifference18%

- Check33 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, signaling a maintenance update to the page version. This update changes only the metadata tag and does not modify study information or user-facing content.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision tag at the bottom changed from v3.6.5 to v3.6.6, indicating a newer page version. This appears to be a minor update to the page's release version rather than a substantive content change.SummaryDifference0.1%

- Check54 days agoChange DetectedThis change adds '2018 ( U.S. NIH Grant/Contract )' under the study's identifiers, indicating NIH funding for the ACROBAT Evolve trial.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5. This reflects an update to the page's content and related documentation.SummaryDifference0.1%

Stay in the know with updates to Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page.